Jun 17, 2025
Оfftopic Community
Оfftopic Community
Forums
New posts
Search forums
What's new
Featured content
New posts
New media
New media comments
New resources
New profile posts
Latest activity
Media
New media
New comments
Search media
Resources
Latest reviews
Search resources
Members
Current visitors
New profile posts
Search profile posts
Log in
Register
What's new
Search
Search
Search titles only
By:
New posts
Search forums
Menu
Log in
Register
Install the app
Install
Forums
Information & News
RSS News
Health and Fitness
FDA Approves Ampyra To Improve Walking In Adults With Multiple Sclerosis
JavaScript is disabled. For a better experience, please enable JavaScript in your browser before proceeding.
You are using an out of date browser. It may not display this or other websites correctly.
You should upgrade or use an
alternative browser
.
Reply to thread
Message
<blockquote data-quote="tD33NAt" data-source="post: 2080653" data-attributes="member: 124445"><p>The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use. MS is a chronic, often disabling, disease that affects the central nervous system the brain, spinal cord, and optic nerves. There are about 400,000 people in the United States and 2.5 million people world-wide with MS... <a href="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/0/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/0/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p><a href="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/1/da" target="_blank"><img src="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/1/di" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></a></p><p></p><p><img src="http://feeds.feedburner.com/~r/mnt/healthnews/~4/aMyUqbZQRUY" alt="" class="fr-fic fr-dii fr-draggable " data-size="" style="" /></p><p></p><p><a href="http://feedproxy.google.com/~r/mnt/healthnews/~3/aMyUqbZQRUY/3wHN" target="_blank">More...</a></p></blockquote><p></p>
[QUOTE="tD33NAt, post: 2080653, member: 124445"] The U.S. Food and Drug Administration approved Ampyra (dalfampridine) extended release tablets to improve walking in patients with multiple sclerosis (MS). In clinical trials, patients treated with Ampyra had faster walking speeds than those treated with an inactive pill (placebo). This is the first drug approved for this use. MS is a chronic, often disabling, disease that affects the central nervous system the brain, spinal cord, and optic nerves. There are about 400,000 people in the United States and 2.5 million people world-wide with MS... [URL="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/0/da"][IMG]http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/0/di[/IMG][/URL] [URL="http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/1/da"][IMG]http://feedads.g.doubleclick.net/~a/lYMWI1stGxrRXR2YQ1xo_TtIHz8/1/di[/IMG][/URL] [IMG]http://feeds.feedburner.com/~r/mnt/healthnews/~4/aMyUqbZQRUY[/IMG] [url=http://feedproxy.google.com/~r/mnt/healthnews/~3/aMyUqbZQRUY/3wHN]More...[/url] [/QUOTE]
Insert quotes…
Name
Verification
Please enable JavaScript to continue.
Loading…
Post reply
Top